Skip to search formSkip to main contentSkip to account menu

Humira

National Institutes of Health

Related topics

Related topics

4 relations
0.2 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]0.4 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]0.8 ML adalimumab 50 MG/ML Injection [Humira]

Broader (1)

adalimumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®
Quality by design (QbD) is an efficient but challenging approach for the development of biosimilar due to the complex… 
Highly Cited
2019
Highly Cited
2019
Top drugs and companies by sales in 2018
2019
2019
Demonstration of functional similarity of a biosimilar adalimumab SB5 to Humira®.
2018
2018
Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects
The aims of this randomized, double‐blind, three‐arm, single‐dose study were to demonstrate pharmacokinetic (PK) equivalence of… 
2016
2016
Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®
ABSTRACT Biosimilars are biological products that are highly similar to existing products approved by health authorities… 
2016
2016
Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira® in healthy subjects
Aims The aim of the study was to compare the pharmacokinetics (PK), safety and tolerability of the proposed adalimumab biosimilar… 
2016
2016
Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
ONS-3010 is being developed by Oncobiologics Inc. (Cranbury, NJ, USA) as a biosimilar of Humira®. This randomized, double blind… 
2012
2012
Die‐Off Ratio Correlates with Increased TNF‐α:IL‐10 Ratio and Decreased IVF Success Rates Correctable with Humira
Human embryos develop at varying rates in culture, with only a fraction of the eggs retrieved developing to ‘transfer quality… 
2011
2011
Birth Defect Rates in Women Using Adalimumab (Humira®) to Treat Immunologic‐Based Infertility in IVF Patients
Citation Winger EE, Reed JL, Ashoush S, El‐Toukhy T, Ahuja S, Taranissi M. Birth defect rates in women using Adalimumab (Humira… 
2004
2004
Humira (adalimumab).
FDA-Approved Indications  Moderately to severely active rheumatoid arthritis (RA)  Moderately to severely active polyarticular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)